(Q35946046)

11 August 2017

1 reference

title

The effectiveness of atypical antipsychotic medications in depressive disorders (English)

1 reference

11 August 2017

Waguih William Ishak

1

0 references

author name string

Mark H Rapaport

series ordinal

2

1 reference

PubMed ID

15538989

11 August 2017

Jennifer G Gotto

series ordinal

3

1 reference

PubMed ID

15538989

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Current Psychiatry Reports

11 August 2017

1 reference

11 August 2017

6

1 reference

11 August 2017

6

1 reference

11 August 2017

422-424

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-004-0005-0

11 August 2017

0 references

cites work

Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study.

1 reference

12 December 2020

Augmentation of milnacipran by risperidone in treatment for major depression.

1 reference

12 December 2020

Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients

1 reference

12 December 2020

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder

1 reference

12 December 2020

Atypical antipsychotics and suicide in mood and anxiety disorders

1 reference

12 December 2020

The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia

1 reference

12 December 2020

The role of atypical antipsychotics in bipolar depression and anxiety disorders

1 reference

12 December 2020

Dopamine partial agonists: a new class of antipsychotic

1 reference

12 December 2020

Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.

1 reference

12 December 2020

An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy.

1 reference

12 December 2020

Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study

1 reference

12 December 2020

The efficacy of atypical antipsychotics in bipolar disorders.

1 reference

12 December 2020

Spotlight on ziprasidone in schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors

1 reference

12 December 2020

Olanzapine augmentation in the treatment of melancholia: the trajectory of improvement in rapid responders

1 reference

12 December 2020

Using antipsychotic agents in older patients

1 reference

12 December 2020

A novel augmentation strategy for treating resistant major depression

1 reference

12 December 2020

Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate.

1 reference

12 December 2020

10.1007/S11920-004-0005-0

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15538989